# US 2008/0305544 A1 · Method of Producing Nerve Cell

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0305544 A1
- Document ID: US20080305544A1
- Status: Published application
- Kind: A1
- Application number: 11/571,580
- Filed: 2005-07-06
- Published: 2008-12-11
- Earliest claimed: 2004-07-06
- Assignees: Hiroo Iwata; Kyowa Hakko Kogyo Co., Ltd. Tokyo, Japan
- Inventors: Hiroo Iwata; Yoshiki Sasai; Hironori Yamazoe; Masato Kobori; Mitsuo Satoh; Keiichi Yano
- Web page: https://patentgrep.com/patent/US20080305544A1

## CPC

- C12N 5/0619: {Neurons}
- C12N 2500/38: Vitamins
- C12N 2506/02: from embryonic cells
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

An Object of the present invention is to provide a process for producing a nerve cell by inducing differentiation of an embryonic stem cell, a method for inducing differentiation of the embryonic stem cell into a nerve cell, a medium to be used in the production process or differentiation induction method, or a method for improving purity of the nerve cell obtained by inducing differentiation of the embryonic stem cell. The present invention provides a process for producing a nerve cell which is applicable to treatment of neurodegenerative disease or the like easily, selectively or inexpensively by inducing differentiation induction of an embryonic stem cell using vitamin B12 or a salt thereof and heparin, a substance having heparin-like activity or a salt.

## Claims

### Claim 1

A process for producing a nerve cell, which comprises a step of culturing an embryonic stem cell under non-aggregation conditions using vitamin B12 or a salt thereof and heparin, a substance having heparin-like activity or a salt thereof to thereby induce differentiation into a nerve cell, and isolating a nerve cell from the culture.

### Claim 2 (depends on 1)

The process according to claim 1, wherein the nerve cell is a catecholaminergic neuron.

### Claim 3 (depends on 2)

The process according to claim 2, wherein the catecholaminergic neuron is a dopaminergic neuron.

### Claim 4 (depends on 1, 2, 3)

The process according to any one of claims 1 to 3, wherein the differentiation induction is carried out in a serum-free medium.

### Claim 5 (depends on 4)

The process according to claim 4, wherein the differentiation is induced without utilizing such activity owned by a stroma cell that induces differentiation of an embryonic stem cell into an ectodermal cell or an ectoderm-derived cell.

### Claim 6 (depends on 4)

The process according to claim 4, wherein the serum-free medium is a serum-free medium which comprises one or more compounds selected from biotin or a salt thereof, a polyamine and an iron-containing compound.

### Claim 7 (depends on 17)

A medium having activity of inducing differentiation of an embryonic stem cell into a nerve cell, which is used for the process described in claim 17.

### Claim 8

A method for inducing differentiation of an embryonic stem cell into a nerve cell, which comprises a step of culturing the embryonic stem cell under non-aggregation conditions using vitamin B12 or a salt thereof and heparin, a substance having heparin-like activity or a salt thereof.

### Claim 9 (depends on 8)

The method according to claim 8, wherein the nerve cell is a catecholaminergic neuron.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the catecholaminergic neuron is a dopaminergic neuron.

### Claim 11 (depends on 8, 9, 10)

The method according to any one of claims 8 to 10, wherein the differentiation induction is carried out in a serum-free medium.

### Claim 12 (depends on 11)

The method according to claim 11, wherein said differentiation is induced utilizing such activity owned by a stroma cell that induces differentiation of an embryonic stem cell into an ectodermal cell or an ectoderm-derived cell.

### Claim 13 (depends on 11)

The method according to claim 11, wherein the serum-free medium is a serum-free medium which comprises one or more compounds selected from biotin or a salt thereof, a polyamine and an iron-containing compound.

### Claim 14 (depends on 18)

A medium having activity of inducing differentiation of an embryonic stem cell into a nerve cell, which is used for the method described in claim 18.

### Claim 15

A method for improving purity of a nerve cell obtained by inducing differentiation of an embryonic stem cell, which comprises steps of culturing the embryonic stem cell under non-aggregation conditions using vitamin B12 or a salt thereof and heparin, a substance having heparin-like activity or a salt thereof, and then culturing in a medium containing an anticancer agent.

### Claim 16 (depends on 15)

The method according to claim 15, wherein the anticancer agent is an anticancer agent selected from the group consisting of mitomycin C, 5-fluorouracil, adriamycin, Ara-C and methotrexate.

### Claim 17 (depends on 5)

The process according to claim 5, wherein the serum-free medium is a serum-free medium which comprises one or more compounds selected from biotin or a salt thereof, a polyamine and an iron-containing compound.

### Claim 18 (depends on 12)

The method according to claim 12, wherein the serum-free medium is a serum-free medium which comprises one or more compounds selected from biotin or a salt thereof, a polyamine and an iron-containing compound.
